Brochure | February 9, 2021

Daikyo Crystal Zenith®

Of all the research, planning and analysis that goes into the creation of a promising new therapy, the choice of a containment system might seem like a minor decision. In fact, it could be one of the most important.

The Crystal Zenith (CZ) polymer addresses the need for a clear, biocompatible material that overcomes problems inherent in glass vials, syringes and cartridges. Drug containment and delivery systems manufactured from the versatile, technologically advanced CZ polymer are ideal for high-value molecules, biologicals and biopharmaceuticals, where glass may be a less desirable option because of issues such as chemical interactions and breakage.

As a full product lifecycle solution, CZ can eliminate a host of serious problems downstream, including shortages and recalls caused by containment and delivery system defects or interactions. In fact, since 2006 there have been over 25 FDA recalls for breakage and another 20+ for particulates—recalls of over 100 million drug units in total.

By using CZ from the start, you can move your molecule from the research and development lab, through development and clinical trials, into commercialization, all in containers manufactured from the same polymer. This can help eliminate worries about unexpected interactions, breakage issues or storage concerns.

VIEW THE BROCHURE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to:

West Pharmaceutical Services, Inc.